We are live on ! Find out more
EBS icon

Emergent Biosolutions
EBS

162 hedge funds and large institutions have $629M invested in Emergent Biosolutions in 2014 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 57 increasing their positions, 57 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 14

1.73% more ownership

Funds ownership: 77.92% → 79.65% (+1.7%)

1% more funds holding

Funds holding: 160 → 162 (+2)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 57

4% less capital invested

Capital invested by funds: $655M → $629M (-$25.3M)

Holders
162
Holders Change
+2
Holders Change %
+1.25%
% of All Funds
4.7%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
16
Increased
57
Reduced
57
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
FMA
Fiduciary Management Associates
Illinois
+$14.9M
2
GC
Guggenheim Capital
Illinois
+$9.07M
3
GPP
Great Point Partners
Connecticut
+$6.64M
4
KCM
Kennedy Capital Management
Missouri
+$6M
5
CM
Castleark Management
Illinois
+$4.13M

Top Sellers

Rank Fund Capital Flow
1
NI
Numeric Investors
Massachusetts
-$14.3M
2
PAM
Panagora Asset Management
Massachusetts
-$5.33M
3
GAM
Gotham Asset Management
New York
-$4.99M
4
Morgan Stanley
Morgan Stanley
New York
-$3.44M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$2.82M
Name Holding Trade Value Shares
Change 		Change in
Stake
GPP
26
Great Point Partners
Connecticut
$6.18M +$6.64M +290,000 New
AQR Capital Management
27
AQR Capital Management
Connecticut
$5.89M -$2.31M -101,100 -27%
KCM
28
Kennedy Capital Management
Missouri
$5.59M +$6M +262,156 New
IA
29
Icon Advisers
Colorado
$5.51M +$1.59M +69,300 +37%
SCP
30
Seizert Capital Partners
Michigan
$5.35M +$2.06M +89,965 +56%
Ameriprise
31
Ameriprise
Minnesota
$5.29M +$2.63M +114,980 +86%
SO
32
STRS Ohio
Ohio
$4.84M -$20.6K -900 -0.4%
CM
33
Castleark Management
Illinois
$4.55M +$4.13M +180,225 New
RFC
34
Russell Frank Company
Washington
$4.25M -$1.22M -53,370 -21%
American Century Companies
35
American Century Companies
Missouri
$4.09M +$352K +15,371 +9%
Arrowstreet Capital
36
Arrowstreet Capital
Massachusetts
$3.94M +$1.27M +55,248 +43%
Geode Capital Management
37
Geode Capital Management
Massachusetts
$3.94M +$428K +18,685 +11%
CRC
38
Curi RMB Capital
Illinois
$3.8M +$63K +2,752 +2%
Principal Financial Group
39
Principal Financial Group
Iowa
$3.75M -$92.7K -4,047 -2%
MOACM
40
Mutual of America Capital Management
New York
$3.45M – – –
NAP
41
New Amsterdam Partners
New York
$3.4M +$497K +21,718 +16%
Jacobs Levy Equity Management
42
Jacobs Levy Equity Management
New Jersey
$3.02M -$445K -19,440 -12%
AAM
43
Aberdeen Asset Management
United Kingdom
$2.86M +$621K +27,100 +25%
TCIM
44
TIAA CREF Investment Management
New York
$2.79M -$719K -31,382 -19%
Citadel Advisors
45
Citadel Advisors
Florida
$2.67M +$2.61M +113,848 +1,000%
PPA
46
Parametric Portfolio Associates
Washington
$2.65M +$63.8K +2,785 +2%
CCMH
47
Cornerstone Capital Management Holdings
New York
$2.54M +$1.08M +47,200 +65%
BA
48
BlackRock Advisors
Delaware
$2.36M -$170K -7,403 -6%
BIM
49
BlackRock Investment Management
Delaware
$2.29M +$30K +1,311 +1%
GCP
50
GSA Capital Partners
United Kingdom
$2.27M +$532K +23,234 +28%
1
2
3 4 5

EBS Hedge Fund Activity: Q3 2014 in Review

162 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Emergent Biosolutions (EBS) for Q3 2014, worth a combined $629M — down 3.9% from $655M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new EBS positions and 14 closed out — a net gain of 2 holders — while 57 added to existing stakes and 57 trimmed.

The largest buyer was Fiduciary Management Associates, opening a new position worth an estimated $14.9M. The largest seller was Numeric Investors, exiting entirely with an estimated $14.3M sold.

  • 162 institutional investors held Emergent Biosolutions (EBS) as of Q3 2014, up from 160 in Q2 2014.
  • Funds reported $629M of Emergent Biosolutions stock for Q3 2014, down 3.9% quarter-over-quarter.
  • 16 funds opened new Emergent Biosolutions positions in Q3 2014 and 14 closed out, a net change of +2 holders.
  • The largest Emergent Biosolutions buyer in Q3 2014 was Fiduciary Management Associates, an estimated $14.9M added.
  • The largest Emergent Biosolutions seller in Q3 2014 was Numeric Investors, an estimated $14.3M sold.

Based on aggregated 13F filings for Q3 2014.